DNTH · Dianthus Therapeutics, Inc. /DE/
← all insidersPharmaceutical Preparations · Listed on Nasdaq
Open-market insider flow over 30d · 90d · 180d · 365d · filter in table · CSV · JSON
Open-market trades45
Distinct insiders7
Bought$0
Sold$44.56M
Net flow$-44.56M
Recent filings
How to read this
- Filed
- Date the Form 4 was filed with the SEC. Insiders must file within 2 business days of the trade.
- Ticker
- The issuer's stock symbol. Select it to open that company's insider-activity page.
- Issuer
- The company whose shares were traded.
- Sector
- The issuer's industry (SEC SIC classification). Select a value to filter to that sector.
- Insider
- The reporting person: an officer, director, or 10% owner. Select a name to see all of their trades.
- Role
- The insider's relationship to the company: director, officer, or 10% owner.
- Code
- SEC transaction code describing the kind of transaction. Full official definitions are under “Transaction codes” below. A dot marks an open-market trade (P/S), the highest-conviction signal.
- Side
- Direction of the trade, from the filing's Acquired (A) ▲ / Disposed of (D) ▼ field: a buy or a sell.
- 10b5-1
- Trade made under a pre-arranged Rule 10b5-1 plan: scheduled in advance, not a discretionary decision (generally lower signal).
- Shares
- Number of shares in this transaction.
- Price
- Reported price per share. Blank for grants, gifts, and other trades with no stated price.
- Value
- Transaction value = shares × price. Left blank for grants, option exercises, gifts, and conversions, which have no cash price (see Own Δ for their impact).
- Owned after
- Form 4 column “Amount of Securities Beneficially Owned Following Reported Transaction(s)”: shares the insider held (directly or indirectly) immediately after this trade.
- Own Δ
- How much this trade changed the insider's own holding versus what they held just before it (not a share of the company). +45% grew it by 45%, 2.0× more than doubled it, −100% sold the entire stake, “new” built a position from nothing.
- Co. Δ
- Change in the insider's stake as a share of the whole company from this trade (transaction shares ÷ shares outstanding). The “(now …)” figure is their resulting total stake. Based on the latest reported shares outstanding; blank when unavailable.
- D/I
- Form 4 column “Ownership Form: Direct (D) or Indirect (I)”. Indirect holdings (for example, through a trust, fund, or family member) are detailed in the filing's “Nature of Indirect Beneficial Ownership.”
- Lag
- Days from the trade date to the filing date (Form 4 is due within 2 business days).
Transaction codes
Verbatim from the SEC's General Instructions for Forms 3, 4 and 5.
- P
- Open market or private purchase of non-derivative or derivative security
- S
- Open market or private sale of non-derivative or derivative security
- A
- Grant, award or other acquisition pursuant to Rule 16b-3(d)
- D
- Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
- F
- Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
- M
- Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
- G
- Bona fide gift
- C
- Conversion of derivative security
- X
- Exercise of in-the-money or at-the-money derivative security
- J
- Other acquisition or disposition (describe transaction)
| Filed ↓Date the Form 4 was filed with the SEC (due within 2 business days of the trade). | Insider | Role | CodeSEC transaction code describing the kind of transaction. See “How to read this” above for the official SEC definition of each code. The dot marks an open-market trade (P/S). | SideDirection of the trade: a buy (acquired ▲) or a sell (disposed ▼). | Shares | PriceReported price per share. Blank for trades with no stated price. | ValueTransaction value = shares × price. Left blank for grants, option exercises, gifts, and conversions, which have no cash price (see Own Δ). | Owned afterShares the insider held (directly or indirectly) immediately after this trade. | Own ΔHow much this trade changed the insider's own holding versus what they held just before it (not a share of the company). +45% grew it by 45%, 2.0× more than doubled it, −100% sold the entire stake, “new” built a position from nothing. | Co. ΔChange in the insider's stake as a share of the whole company from this trade (transaction shares ÷ shares outstanding). The “(now …)” figure is their resulting total stake in the company. Based on the latest reported shares outstanding; blank when unavailable. | Link to SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-03 | Randhawa Simrat | Officer (EVP, Head of R&D) | M | ▼ sell10b5-1 | 9,375→ 9,375 Common Stock | — | — | 87,500 | — | — | filing |
| 2026-09-03 | Randhawa Simrat | Officer (EVP, Head of R&D) | M | ▼ sell10b5-1 | 6,249→ 6,249 Common Stock | — | — | 41,676 | — | — | filing |
| 2026-09-03 | Randhawa Simrat | Officer (EVP, Head of R&D) | M | ▼ sell10b5-1 | 7,500→ 7,500 Common Stock | — | — | 56,776 | — | — | filing |
| 2026-09-03 | Randhawa Simrat | Officer (EVP, Head of R&D) | S | ▼ sell10b5-1 | 13,3090 | $106.74 | $1.42M | 4,000 | −77% | −0.02% (now <0.01%) | filing |
| 2026-09-03 | Randhawa Simrat | Officer (EVP, Head of R&D) | S | ▼ sell10b5-1 | 7,2150 | $106.25 | $766.6K | 17,309 | −29% | −0.01% (now 0.03%) | filing |
| 2026-09-03 | Randhawa Simrat | Officer (EVP, Head of R&D) | S | ▼ sell10b5-1 | 2,6000 | $105.19 | $273.5K | 24,524 | −10% | −<0.01% (now 0.04%) | filing |
| 2026-09-03 | Randhawa Simrat | Officer (EVP, Head of R&D) | M | ▲ buy10b5-1 | 9,3750 | $22.07 | $206.9K | 27,124 | +53% | +0.02% (now 0.05%) | filing |
| 2026-09-03 | Randhawa Simrat | Officer (EVP, Head of R&D) | M | ▲ buy10b5-1 | 6,2490 | $21.77 | $136.0K | 17,749 | +54% | +0.01% (now 0.03%) | filing |
| 2026-09-03 | Randhawa Simrat | Officer (EVP, Head of R&D) | M | ▲ buy10b5-1 | 7,5000 | $17.88 | $134.1K | 11,500 | 2.9× | +0.01% (now 0.02%) | filing |
| 2026-08-19 | Read Simon | Director | M | ▼ sell10b5-1 | 2,778→ 2,778 Common Stock | — | — | 19,445 | — | — | filing |
| 2026-08-19 | Read Simon | Director | S | ▼ sell10b5-1 | 2,7780 | $117.55 | $326.6K | 0 | −100% | −<0.01% (now 0%) | filing |
| 2026-08-19 | Read Simon | Director | M | ▲ buy10b5-1 | 2,7780 | $18.36 | $51.0K | 2,778 | new | +<0.01% (now <0.01%) | filing |
| 2026-08-14 | Veness Adam M | Officer (SVP, General Counsel and Sec.) | M | ▼ sell | 15,000→ 15,000 Common Stock | — | — | 73,240 | — | — | filing |
| 2026-08-14 | Veness Adam M | Officer (SVP, General Counsel and Sec.) | M | ▲ buy | 15,0000 | $18.17 | $272.6K | 15,000 | new | +0.03% (now 0.03%) | filing |
| 2026-08-11 | McGeorge Anne | Director | M | ▼ sell10b5-1 | 6,500→ 6,500 Common Stock | — | — | 0 | — | — | filing |
| 2026-08-11 | McGeorge Anne | Director | M | ▼ sell10b5-1 | 1,250→ 1,250 Common Stock | — | — | 0 | — | — | filing |
| 2026-08-11 | McGeorge Anne | Director | S | ▼ sell10b5-1 | 7000 | $111.41 | $78.0K | 0 | −100% | −<0.01% (now 0%) | filing |
| 2026-08-11 | McGeorge Anne | Director | S | ▼ sell10b5-1 | 1,0000 | $110.64 | $110.6K | 700 | −59% | −<0.01% (now <0.01%) | filing |
| 2026-08-11 | McGeorge Anne | Director | S | ▼ sell10b5-1 | 1,8000 | $109.30 | $196.7K | 1,700 | −51% | −<0.01% (now <0.01%) | filing |
| 2026-08-11 | McGeorge Anne | Director | S | ▼ sell10b5-1 | 2,8000 | $108.38 | $303.5K | 3,500 | −44% | −<0.01% (now <0.01%) | filing |
| 2026-08-11 | McGeorge Anne | Director | S | ▼ sell10b5-1 | 1,4500 | $107.58 | $156.0K | 6,300 | −19% | −<0.01% (now 0.01%) | filing |
| 2026-08-11 | McGeorge Anne | Director | M | ▲ buy10b5-1 | 6,5000 | $11.20 | $72.8K | 7,750 | 6.2× | +0.01% (now 0.01%) | filing |
| 2026-08-11 | McGeorge Anne | Director | M | ▲ buy10b5-1 | 1,2500 | $19.36 | $24.2K | 1,250 | new | +<0.01% (now <0.01%) | filing |
| 2026-08-11 | Veness Adam M | Officer (SVP, General Counsel and Sec.) | M | ▼ sell10b5-1 | 16,167→ 16,167 Common Stock | — | — | 60,000 | — | — | filing |
| 2026-08-11 | Veness Adam M | Officer (SVP, General Counsel and Sec.) | M | ▼ sell10b5-1 | 3,833→ 3,833 Common Stock | — | — | 76,167 | — | — | filing |
| 2026-08-11 | Veness Adam M | Officer (SVP, General Counsel and Sec.) | S | ▼ sell10b5-1 | 16,1670 | $110.38 | $1.78M | 0 | −100% | −0.03% (now 0%) | filing |
| 2026-08-11 | Veness Adam M | Officer (SVP, General Counsel and Sec.) | M | ▲ buy10b5-1 | 16,1670 | $17.88 | $289.1K | 16,167 | new | +0.03% (now 0.03%) | filing |
| 2026-08-11 | Veness Adam M | Officer (SVP, General Counsel and Sec.) | S | ▼ sell10b5-1 | 6160 | $111.18 | $68.5K | 0 | −100% | −<0.01% (now 0%) | filing |
| 2026-08-11 | Veness Adam M | Officer (SVP, General Counsel and Sec.) | S | ▼ sell10b5-1 | 3,2170 | $110.61 | $355.8K | 616 | −84% | −<0.01% (now <0.01%) | filing |
| 2026-08-11 | Veness Adam M | Officer (SVP, General Counsel and Sec.) | M | ▲ buy10b5-1 | 3,8330 | $17.88 | $68.5K | 3,833 | new | +<0.01% (now <0.01%) | filing |
| 2026-08-11 | Read Simon | Director | M | ▼ sell10b5-1 | 2,777→ 2,777 Common Stock | — | — | 22,223 | — | — | filing |
| 2026-08-11 | Read Simon | Director | S | ▼ sell10b5-1 | 3970 | $111.77 | $44.4K | 0 | −100% | −<0.01% (now 0%) | filing |
| 2026-08-11 | Read Simon | Director | S | ▼ sell10b5-1 | 4700 | $111.05 | $52.2K | 397 | −54% | −<0.01% (now <0.01%) | filing |
| 2026-08-11 | Read Simon | Director | S | ▼ sell10b5-1 | 2720 | $109.96 | $29.9K | 867 | −24% | −<0.01% (now <0.01%) | filing |
| 2026-08-11 | Read Simon | Director | S | ▼ sell10b5-1 | 8310 | $108.95 | $90.5K | 1,139 | −42% | −<0.01% (now <0.01%) | filing |
| 2026-08-11 | Read Simon | Director | S | ▼ sell10b5-1 | 7370 | $108.17 | $79.7K | 1,970 | −27% | −<0.01% (now <0.01%) | filing |
| 2026-08-11 | Read Simon | Director | S | ▼ sell10b5-1 | 700 | $107.11 | $7.5K | 2,707 | −3% | −<0.01% (now <0.01%) | filing |
| 2026-08-11 | Read Simon | Director | M | ▲ buy10b5-1 | 2,7770 | $18.36 | $51.0K | 2,777 | new | +<0.01% (now <0.01%) | filing |
| 2026-08-07 | Garcia Marino | Director, Officer (CEO AND PRESIDENT) | M | ▼ sell10b5-1 | 126,000→ 126,000 Common Stock | — | — | 160,004 | — | — | filing |
| 2026-08-07 | Garcia Marino | Director, Officer (CEO AND PRESIDENT) | M | ▼ sell10b5-1 | 40,000→ 40,000 Common Stock | — | — | 286,004 | — | — | filing |
| 2026-08-07 | Garcia Marino | Director, Officer (CEO AND PRESIDENT) | S | ▼ sell10b5-1 | 21,9090 | $108.72 | $2.38M | 65,292 | −25% | −0.04% (now 0.12%) | filing |
| 2026-08-07 | Garcia Marino | Director, Officer (CEO AND PRESIDENT) | S | ▼ sell10b5-1 | 104,0910 | $107.96 | $11.24M | 87,102 | −54% | −0.19% (now 0.16%) | filing |
| 2026-08-07 | Garcia Marino | Director, Officer (CEO AND PRESIDENT) | S | ▼ sell10b5-1 | 8000 | $110.76 | $88.6K | 191,292 | −0.4% | −<0.01% (now 0.34%) | filing |
| 2026-08-07 | Garcia Marino | Director, Officer (CEO AND PRESIDENT) | S | ▼ sell10b5-1 | 2,5360 | $110.02 | $279.0K | 192,092 | −1% | −<0.01% (now 0.34%) | filing |
| 2026-08-07 | Garcia Marino | Director, Officer (CEO AND PRESIDENT) | S | ▼ sell10b5-1 | 2,3730 | $109.10 | $258.9K | 194,628 | −1% | −<0.01% (now 0.35%) | filing |
| 2026-08-07 | Garcia Marino | Director, Officer (CEO AND PRESIDENT) | S | ▼ sell10b5-1 | 23,9070 | $108.05 | $2.58M | 197,001 | −11% | −0.04% (now 0.35%) | filing |
| 2026-08-07 | Garcia Marino | Director, Officer (CEO AND PRESIDENT) | S | ▼ sell10b5-1 | 10,3840 | $107.49 | $1.12M | 220,908 | −4% | −0.02% (now 0.39%) | filing |
| 2026-08-07 | Garcia Marino | Director, Officer (CEO AND PRESIDENT) | M | ▲ buy10b5-1 | 126,0000 | $8.44 | $1.06M | 231,292 | 2.2× | +0.23% (now 0.41%) | filing |
| 2026-08-07 | Garcia Marino | Director, Officer (CEO AND PRESIDENT) | M | ▲ buy10b5-1 | 40,0000 | $8.44 | $337.6K | 105,292 | +61% | +0.07% (now 0.19%) | filing |
| 2026-07-13 | Savitz Ryan | Officer (EVP, CFO & CBO) | M | ▼ sell10b5-1 | 31,249→ 31,249 Common Stock | — | — | 68,751 | — | — | filing |
| 2026-07-13 | Savitz Ryan | Officer (EVP, CFO & CBO) | S | ▼ sell10b5-1 | 5,5660 | $101.97 | $567.6K | 0 | −100% | −<0.01% (now 0%) | filing |
| 2026-07-13 | Savitz Ryan | Officer (EVP, CFO & CBO) | S | ▼ sell10b5-1 | 15,3290 | $101.24 | $1.55M | 5,566 | −73% | −0.03% (now <0.01%) | filing |
| 2026-07-13 | Savitz Ryan | Officer (EVP, CFO & CBO) | S | ▼ sell10b5-1 | 10,3540 | $100.22 | $1.04M | 20,895 | −33% | −0.02% (now 0.04%) | filing |
| 2026-07-13 | Savitz Ryan | Officer (EVP, CFO & CBO) | M | ▲ buy10b5-1 | 31,2490 | $21.77 | $680.3K | 31,249 | new | +0.06% (now 0.06%) | filing |
| 2026-06-18 | Veness Adam M | Officer (SVP, General Counsel and Sec.) | M | ▼ sell10b5-1 | 30,000→ 30,000 Common Stock | — | — | 80,000 | — | — | filing |
| 2026-06-18 | Veness Adam M | Officer (SVP, General Counsel and Sec.) | S | ▼ sell10b5-1 | 13,2290 | $81.38 | $1.08M | 0 | −100% | −0.02% (now 0%) | filing |
| 2026-06-18 | Veness Adam M | Officer (SVP, General Counsel and Sec.) | S | ▼ sell10b5-1 | 16,7710 | $80.34 | $1.35M | 13,229 | −56% | −0.03% (now 0.02%) | filing |
| 2026-06-18 | Veness Adam M | Officer (SVP, General Counsel and Sec.) | M | ▲ buy10b5-1 | 30,0000 | $17.88 | $536.4K | 30,000 | new | +0.05% (now 0.05%) | filing |
| 2026-06-02 | Randhawa Simrat | Officer (EVP, Head of R&D) | M | ▼ sell10b5-1 | 9,375→ 9,375 Common Stock | — | — | 96,875 | — | — | filing |
| 2026-06-02 | Randhawa Simrat | Officer (EVP, Head of R&D) | M | ▼ sell10b5-1 | 6,249→ 6,249 Common Stock | — | — | 47,925 | — | — | filing |
| 2026-06-02 | Randhawa Simrat | Officer (EVP, Head of R&D) | M | ▼ sell10b5-1 | 6,908→ 6,908 Common Stock | — | — | 64,276 | — | — | filing |
| 2026-06-02 | Randhawa Simrat | Officer (EVP, Head of R&D) | M | ▼ sell10b5-1 | 3,998→ 3,998 Common Stock | — | — | 0 | — | — | filing |
| 2026-06-02 | Randhawa Simrat | Officer (EVP, Head of R&D) | S | ▼ sell10b5-1 | 4,1590 | $91.37 | $380.0K | 4,000 | −51% | −<0.01% (now <0.01%) | filing |
| 2026-06-02 | Randhawa Simrat | Officer (EVP, Head of R&D) | S | ▼ sell10b5-1 | 16,9430 | $90.72 | $1.54M | 8,159 | −67% | −0.03% (now 0.01%) | filing |
| 2026-06-02 | Randhawa Simrat | Officer (EVP, Head of R&D) | S | ▼ sell10b5-1 | 5,4280 | $89.72 | $487.0K | 25,102 | −18% | −<0.01% (now 0.04%) | filing |
| 2026-06-02 | Randhawa Simrat | Officer (EVP, Head of R&D) | M | ▲ buy10b5-1 | 9,3750 | $22.07 | $206.9K | 30,530 | +44% | +0.02% (now 0.05%) | filing |
| 2026-06-02 | Randhawa Simrat | Officer (EVP, Head of R&D) | M | ▲ buy10b5-1 | 6,2490 | $21.77 | $136.0K | 21,155 | +42% | +0.01% (now 0.04%) | filing |
| 2026-06-02 | Randhawa Simrat | Officer (EVP, Head of R&D) | M | ▲ buy10b5-1 | 6,9080 | $17.88 | $123.5K | 14,906 | +86% | +0.01% (now 0.03%) | filing |
| 2026-06-02 | Randhawa Simrat | Officer (EVP, Head of R&D) | M | ▲ buy10b5-1 | 3,9980 | $8.44 | $33.7K | 7,998 | +100% | +<0.01% (now 0.01%) | filing |
| 2026-05-22 | McGeorge Anne | Director | A | ▲ buy | 6,090→ 6,090 Common Stock | — | — | 6,090 | — | — | filing |
| 2026-05-22 | Violin Jonathan | Director | A | ▲ buy | 6,090→ 6,090 Common Stock | — | — | 6,090 | — | — | filing |
| 2026-05-22 | Soteropoulos Paula | Director | A | ▲ buy | 6,090→ 6,090 Common Stock | — | — | 6,090 | — | — | filing |
| 2026-05-22 | Read Simon | Director | A | ▲ buy | 6,090→ 6,090 Common Stock | — | — | 6,090 | — | — | filing |
| 2026-05-22 | Romano Steven J. | Director | A | ▲ buy | 6,090→ 6,090 Common Stock | — | — | 6,090 | — | — | filing |
| 2026-05-22 | Lawton Alison Frances | Director | A | ▲ buy | 6,090→ 6,090 Common Stock | — | — | 6,090 | — | — | filing |
| 2026-05-22 | KANGO SUJAY | Director | A | ▲ buy | 6,090→ 6,090 Common Stock | — | — | 6,090 | — | — | filing |
| 2026-05-11 | Soteropoulos Paula | Director | M | ▼ sell10b5-1 | 599→ 599 Common Stock | — | — | 0 | — | — | filing |
| 2026-05-11 | Soteropoulos Paula | Director | S | ▼ sell10b5-1 | 5990 | $85.47 | $51.2K | 0 | −100% | −<0.01% (now 0%) | filing |
| 2026-05-11 | Soteropoulos Paula | Director | M | ▲ buy10b5-1 | 5990 | $8.44 | $5.1K | 599 | new | +<0.01% (now <0.01%) | filing |
| 2026-04-10 | Savitz Ryan | Officer (EVP, CFO & CBO) | M | ▼ sell10b5-1 | 8,224→ 8,224 Common Stock | — | — | 71,776 | — | — | filing |
| 2026-04-10 | Savitz Ryan | Officer (EVP, CFO & CBO) | S | ▼ sell10b5-1 | 8,2240 | $89.84 | $738.8K | 0 | −100% | −0.01% (now 0%) | filing |
| 2026-04-10 | Savitz Ryan | Officer (EVP, CFO & CBO) | M | ▲ buy10b5-1 | 8,2240 | $17.88 | $147.0K | 8,224 | new | +0.01% (now 0.01%) | filing |
| 2026-04-01 | Savitz Ryan | Officer (EVP, CFO & CBO) | M | ▼ sell10b5-1 | 40,000→ 40,000 Common Stock | — | — | 80,000 | — | — | filing |
| 2026-04-01 | Savitz Ryan | Officer (EVP, CFO & CBO) | M | ▼ sell10b5-1 | 74,367→ 74,367 Common Stock | — | — | 10,399 | — | — | filing |
| 2026-04-01 | Savitz Ryan | Officer (EVP, CFO & CBO) | S | ▼ sell10b5-1 | 7,2320 | $85.54 | $618.6K | 0 | −100% | −0.01% (now 0%) | filing |
| 2026-04-01 | Savitz Ryan | Officer (EVP, CFO & CBO) | S | ▼ sell10b5-1 | 19,4690 | $84.57 | $1.65M | 7,232 | −73% | −0.03% (now 0.01%) | filing |
| 2026-04-01 | Savitz Ryan | Officer (EVP, CFO & CBO) | S | ▼ sell10b5-1 | 59,8000 | $83.90 | $5.02M | 26,701 | −69% | −0.11% (now 0.05%) | filing |
| 2026-04-01 | Savitz Ryan | Officer (EVP, CFO & CBO) | S | ▼ sell10b5-1 | 2,3660 | $82.84 | $196.0K | 86,501 | −3% | −<0.01% (now 0.15%) | filing |
| 2026-04-01 | Savitz Ryan | Officer (EVP, CFO & CBO) | S | ▼ sell10b5-1 | 8000 | $81.36 | $65.1K | 88,867 | −0.9% | −<0.01% (now 0.16%) | filing |
| 2026-04-01 | Savitz Ryan | Officer (EVP, CFO & CBO) | S | ▼ sell10b5-1 | 1,4850 | $80.25 | $119.2K | 89,667 | −2% | −<0.01% (now 0.16%) | filing |
| 2026-04-01 | Savitz Ryan | Officer (EVP, CFO & CBO) | S | ▼ sell10b5-1 | 21,8250 | $78.86 | $1.72M | 91,152 | −19% | −0.04% (now 0.16%) | filing |
| 2026-04-01 | Savitz Ryan | Officer (EVP, CFO & CBO) | S | ▼ sell10b5-1 | 1,3900 | $78.33 | $108.9K | 112,977 | −1% | −<0.01% (now 0.20%) | filing |
| 2026-04-01 | Savitz Ryan | Officer (EVP, CFO & CBO) | M | ▲ buy10b5-1 | 40,0000 | $17.88 | $715.2K | 114,367 | +54% | +0.07% (now 0.20%) | filing |
| 2026-04-01 | Savitz Ryan | Officer (EVP, CFO & CBO) | M | ▲ buy10b5-1 | 74,3670 | $8.44 | $627.7K | 74,367 | new | +0.13% (now 0.13%) | filing |
| 2026-04-01 | Soteropoulos Paula | Director | M | ▼ sell10b5-1 | 599→ 599 Common Stock | — | — | 599 | — | — | filing |
| 2026-04-01 | Soteropoulos Paula | Director | S | ▼ sell10b5-1 | 5990 | $80.11 | $48.0K | 0 | −100% | −<0.01% (now 0%) | filing |
| 2026-04-01 | Soteropoulos Paula | Director | M | ▲ buy10b5-1 | 5990 | $8.44 | $5.1K | 599 | new | +<0.01% (now <0.01%) | filing |
| 2026-03-26 | Soteropoulos Paula | Director | M | ▼ sell10b5-1 | 27,594→ 27,594 Common Stock | — | — | 1,198 | — | — | filing |
| 2026-03-26 | Soteropoulos Paula | Director | S | ▼ sell10b5-1 | 27,5940 | $78.05 | $2.15M | 0 | −100% | −0.05% (now 0%) | filing |
| 2026-03-26 | Soteropoulos Paula | Director | M | ▲ buy10b5-1 | 27,5940 | $8.44 | $232.9K | 27,594 | new | +0.05% (now 0.05%) | filing |
Up to 200 most recent filings · select a heading to sort, or open “How to read this” above for definitions · this company on SEC EDGAR.